About this trial
The overall objectives of this study are to investigate the efficacy of extended cannabis treatment to reduce patient exposure to prescription opioids through its use 1) as a non-opioid analgesic treatment, and 2) as a therapy for reducing high-dose opioid use in patients with chronic spine pain.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- THC/CBD
- THC
- Placebo
Treatment groups
157 Participants
are divided into 8 treatment groups8
Treatment groupsSee each treatment group below.
Locations
1University of Colorado Anschutz Medical Campus80045, AuroraColorado, United States
Sponsors and collaborators
University of Colorado, Denver
Lead sponsor
Institute of Cannabis Research
Collaborator
Source ClinicalTrials.gov